Novartis

www.novartis.com

Forum 1
Novartis Campus
Basel
CH-4056
Switzerland

+41 61 324 11 11

Activities

Training & Education | Manufacturing | Drug Delivery | Research & Development | Pharmaceutical

Related Companies

Related Content

Therapeutic: tislelizumab for oncology
Therapeutic: tislelizumab for oncology
Therapeutic: leniolisib for APDS
Therapeutic: leniolisib for APDS
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Sterling Pharma Solutions acquires Novartis Facility in Ireland
Therapeutic: inclisiran for hypercholesterolaemia
Therapeutic: inclisiran for hypercholesterolaemia
Novartis to fund protein degrader therapy research
Novartis to fund protein degrader therapy research
Therapeutics: osilodrostat for Cushing’s disease
Therapeutics: osilodrostat for Cushing’s disease
Novartis to revamp manufacturing with the help of Amazon
Novartis to revamp manufacturing with the help of Amazon
Novartis opens facility for innovative cell and gene therapies in Switzerland
Novartis opens facility for innovative cell and gene therapies in Switzerland
Chinese CDMO purchases former Novartis API facility
Chinese CDMO purchases former Novartis API facility
AveXis chooses BIA Separations to support gene therapy pipeline
AveXis chooses BIA Separations to support gene therapy pipeline
Lonza to buy sterile drug product fill-finish facility from Novartis
Lonza to buy sterile drug product fill-finish facility from Novartis
Glenmark chooses Novartis for respiratory products
Glenmark chooses Novartis for respiratory products
FDA approves Novartis gene therapy with a $2m price tag
FDA approves Novartis gene therapy with a $2m price tag
Novartis starts voluntary recall after peanut contamination scare
Novartis starts voluntary recall after peanut contamination scare
Novartis signs manufacturing memorandum in Saudi Arabia
Novartis signs manufacturing memorandum in Saudi Arabia